Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 1
2013 1
2014 1
2015 3
2016 3
2017 8
2018 6
2019 8
2020 9
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus.
Ejiri K, Miyoshi T, Kihara H, Hata Y, Nagano T, Takaishi A, Toda H, Nanba S, Nakamura Y, Akagi S, Sakuragi S, Minagawa T, Kawai Y, Nishii N, Fuke S, Yoshikawa M, Nakamura K, Ito H; MUSCAT‐HF Study Investigators †. Ejiri K, et al. J Am Heart Assoc. 2020 Aug 18;9(16):e015103. doi: 10.1161/JAHA.119.015103. Epub 2020 Aug 1. J Am Heart Assoc. 2020. PMID: 32805185 Free PMC article. Clinical Trial.
Epoprostenol Therapy for Pulmonary Arterial Hypertension.
Akagi S, Nakamura K, Matsubara H, Ogawa A, Sarashina T, Ejiri K, Ito H. Akagi S, et al. Among authors: ejiri k. Acta Med Okayama. 2015;69(3):129-36. doi: 10.18926/AMO/53519. Acta Med Okayama. 2015. PMID: 26101188 Free article. Review.
Epoprostenol sodium for treatment of pulmonary arterial hypertension.
Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H. Saito Y, et al. Among authors: ejiri k. Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25999730 Free PMC article. Review.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page